Target intelligence / Profile preview

Flavonoid-induced apoptosis pathway

Molecular classification
Other (pathway)
01

Overview

The "Flavonoid-induced apoptosis pathway" encompasses the molecular and cellular signaling routes by which flavonoids stimulate programmed cell death in cancer and other cells. This involves both extrinsic (death receptor-mediated, such as activation of Fas and TNF receptors) and intrinsic (mitochondrial-mediated, such as Bcl-2 family regulation and cytochrome c release) apoptotic pathways. Flavonoids activate the caspase cascade, promote mitochondrial membrane permeabilization, trigger cytochrome c and apoptosome formation, modulate key regulatory proteins (p53, Bcl-2, Bcl-xL, Bax), and may generate reactive oxygen species. These coordinated events lead to chromatin condensation, DNA fragmentation, and cell death, with important implications for anti-cancer therapy[2][3][5][6]. This pathway is a mechanism-of-action for a class of compounds but does not itself constitute a druggable molecular target.

Other names
Flavonoid-mediated apoptosis pathwayFlavonoid-triggered apoptotic signalingFlavonoid-induced cell death pathway
02

Mechanism of action

Induction of intrinsic (mitochondrial) apoptosis pathway (modulation of Bcl-2 family proteins, Bax/Bcl-xL ratio, cytochrome c release) Induction of extrinsic (death receptor-mediated) apoptosis pathway (activation of Fas/TNF receptor family, caspase-8 activation) Activation of caspases (3, 7, 8, and 9) Inhibition of PI3K/Akt and MAPK signaling ROS generation and DNA damage[1][2][3][5][6]

03

Biological functions

ApoptosisCell deathSignal transductionCell cycle arrestAnti-cancer activity
04

Disease associations

CancerOther (potentially inflammation and other proliferative diseases, based on context)
05

Safety considerations

Flavonoids generally have a high safety profile in dietary exposures; therapeutic doses may need further safety evaluation but are usually well tolerated[2]Drug-drug or drug-diet interactions (by modulation of cytochromes P450)Potential for off-target effects at high concentrations
06

Interacting drugs

Apigenin

9 more in the full profile.

07

Biomarkers

Cleaved caspase-3Cleaved PARPIncreased p53 expressionDecreased Bcl-2, Bcl-xL expressionCytochrome c releaseUpregulation of apoptotic/anti-apoptotic gene ratios (Bax/Bcl-2)

Beyond the preview

Go deeper on Flavonoid-induced apoptosis pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Flavonoid-induced apoptosis pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call